Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized heparin in burn patients with inhalation trauma
2012-003289-42Phase 4Terminated
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Inhalation injury and acute respiratory decompensation comparing Nebulized heparin with Placebo (2 arms). Primary endpoint: Ventilator-free days (first 28 days). Started Dec 2012; status: terminated.
02
Drugs
heparin
03
Conditions
Inhalation injuryacute respiratory decompensation
Beyond the preview
Go deeper on 2012-003289-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003289-42.